S&P 500   4,989.32 (-0.44%)
DOW   38,028.74 (+0.67%)
QQQ   416.96 (-1.52%)
AAPL   165.03 (-1.20%)
MSFT   399.52 (-1.17%)
META   484.01 (-3.55%)
GOOGL   154.03 (-1.27%)
AMZN   174.96 (-2.38%)
TSLA   149.16 (-0.51%)
NVDA   804.06 (-5.04%)
AMD   149.40 (-3.66%)
NIO   3.83 (-4.25%)
BABA   68.85 (-0.04%)
T   16.36 (+0.18%)
F   12.09 (+0.25%)
MU   107.39 (-4.06%)
GE   149.19 (-2.45%)
CGC   8.09 (+3.32%)
DIS   112.13 (-0.27%)
AMC   3.24 (+10.96%)
PFE   25.81 (+1.65%)
PYPL   62.16 (+0.10%)
XOM   120.07 (+1.31%)
S&P 500   4,989.32 (-0.44%)
DOW   38,028.74 (+0.67%)
QQQ   416.96 (-1.52%)
AAPL   165.03 (-1.20%)
MSFT   399.52 (-1.17%)
META   484.01 (-3.55%)
GOOGL   154.03 (-1.27%)
AMZN   174.96 (-2.38%)
TSLA   149.16 (-0.51%)
NVDA   804.06 (-5.04%)
AMD   149.40 (-3.66%)
NIO   3.83 (-4.25%)
BABA   68.85 (-0.04%)
T   16.36 (+0.18%)
F   12.09 (+0.25%)
MU   107.39 (-4.06%)
GE   149.19 (-2.45%)
CGC   8.09 (+3.32%)
DIS   112.13 (-0.27%)
AMC   3.24 (+10.96%)
PFE   25.81 (+1.65%)
PYPL   62.16 (+0.10%)
XOM   120.07 (+1.31%)
S&P 500   4,989.32 (-0.44%)
DOW   38,028.74 (+0.67%)
QQQ   416.96 (-1.52%)
AAPL   165.03 (-1.20%)
MSFT   399.52 (-1.17%)
META   484.01 (-3.55%)
GOOGL   154.03 (-1.27%)
AMZN   174.96 (-2.38%)
TSLA   149.16 (-0.51%)
NVDA   804.06 (-5.04%)
AMD   149.40 (-3.66%)
NIO   3.83 (-4.25%)
BABA   68.85 (-0.04%)
T   16.36 (+0.18%)
F   12.09 (+0.25%)
MU   107.39 (-4.06%)
GE   149.19 (-2.45%)
CGC   8.09 (+3.32%)
DIS   112.13 (-0.27%)
AMC   3.24 (+10.96%)
PFE   25.81 (+1.65%)
PYPL   62.16 (+0.10%)
XOM   120.07 (+1.31%)
S&P 500   4,989.32 (-0.44%)
DOW   38,028.74 (+0.67%)
QQQ   416.96 (-1.52%)
AAPL   165.03 (-1.20%)
MSFT   399.52 (-1.17%)
META   484.01 (-3.55%)
GOOGL   154.03 (-1.27%)
AMZN   174.96 (-2.38%)
TSLA   149.16 (-0.51%)
NVDA   804.06 (-5.04%)
AMD   149.40 (-3.66%)
NIO   3.83 (-4.25%)
BABA   68.85 (-0.04%)
T   16.36 (+0.18%)
F   12.09 (+0.25%)
MU   107.39 (-4.06%)
GE   149.19 (-2.45%)
CGC   8.09 (+3.32%)
DIS   112.13 (-0.27%)
AMC   3.24 (+10.96%)
PFE   25.81 (+1.65%)
PYPL   62.16 (+0.10%)
XOM   120.07 (+1.31%)
NASDAQ:CPXX

(CPXX) (CPXX) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$30.24
$30.24
50-Day Range
N/A
52-Week Range
$1.12
$30.36
Volume
N/A
Average Volume
2.62 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CPXX stock logo

About (CPXX) Stock (NASDAQ:CPXX)

Celator Pharmaceuticals, Inc. is an oncology-focused biopharmaceutical company. The Company is engaged in developing products to improve patient outcomes in cancer. The Company's technology platform, CombiPlex, enables the design and evaluation of optimized combinations incorporating traditional chemotherapies, as well as molecularly targeted agents to deliver anti-cancer activity. The Company's product, VYXEOS, a nano-scale liposomal formulation of cytarabine:daunorubicin, in Phase III clinical testing for the treatment of acute myeloid leukemia. The Company also conducted clinical development efforts on CPX-1, a nano-scale liposomal formulation of irinotecan:floxuridine for the treatment of colorectal cancer; and has a preclinical stage product candidate CPX-8, a hydrophobic docetaxel prodrug nanoparticle formulation. The Company operates in the United States and Canada.

CPXX Stock News Headlines

The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Little Bear's Big Trip - Trailer
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
See More Headlines
Receive CPXX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (CPXX) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/10/2016
Today
4/19/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:CPXX
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

CPXX Stock Analysis - Frequently Asked Questions

How were (CPXX)'s earnings last quarter?

(CPXX) (NASDAQ:CPXX) announced its quarterly earnings results on Tuesday, May, 10th. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.15) by $0.01.

What other stocks do shareholders of (CPXX) own?
This page (NASDAQ:CPXX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners